-

Humana Names Dr. Andrew Agwunobi President of Company’s Home Solutions Business

Agwunobi has 20 years of experience as a CEO of for-profit, nonprofit, public and university health systems – bringing a balance of operational leadership and clinical expertise

LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health insurer and health care services company Humana Inc. (NYSE: HUM) has hired health care industry veteran Andrew (Andy) Agwunobi, M.D., MBA, as the new President of the company’s Home Solutions business. Dr. Agwunobi comes to Humana from the University of Connecticut, where he currently serves as interim University President, and as CEO of the UConn Health System. In his new role, Dr. Agwunobi will report directly to Humana President and CEO Bruce Broussard and will serve as a member of Humana’s Management Team, effective Feb. 21.

“Andy is just the person we need for this critical Humana role leading our Home Solutions business,” Broussard said. “He has a real passion for care in the home. He has been responsible for a home health care organization as part of an integrated system. He has extensive operational experience with for-profit and nonprofit organizations, and he’s a doctor – he understands the value of care in the home, why seniors want more of it, and our vision at Humana for making it much easier for people to get the care they need at home.”

Prior to his years with UConn, Dr. Agwunobi led the 14-hospital St. Joseph Health System as COO, and led the 5-hospital Providence Health Care System as CEO. He also served as Secretary for the Florida Agency for Health Care Administration, where he had oversight for the state’s then $16 billion health care administration budget. More recently, as part of his UConn Health CEO role, Dr. Agwunobi has executed strategies that have resulted in significant revenue and operational growth. He also led the development of value-based care at UConn Health including Population Health Management.

Dr. Agwunobi’s strong clinical knowledge – with an aptitude for identifying clinical drivers of cost and opportunities to improve care and the member experience – will help him and his team lower the cost of care for Humana customers, while building a business model focused on patient health outcomes through at-home care.

“I’m excited about Humana’s focus on its Home Solutions business, and especially interested in ways we can transform the home health industry together,” Dr. Agwunobi said. “As the ongoing COVID pandemic has accelerated interest in and shifts to in-home care and home health models, I’m highly confident that we will be able to help the people we serve achieve better health outcomes. My experience to date has prepared me well for this new opportunity with Humana.”

Earlier in his life, after growing up in Scotland and Nigeria, Agwunobi pursued medical student training in Nigeria, and then Scotland. He is a pediatrician who earned his M.D. from the University of Jos in Nigeria, and later an MBA from Stanford University. He completed his residency in pediatrics at Howard University Hospital.

Dr. Agwunobi currently serves on the board of CareQuest. He has most recently served on the Dignity Community Care and Restorix Health boards.

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information

 

Contacts

Kelley Murphy
Humana Corporate Communications
kmurphy26@humana.com
502.224.1755

Humana Inc.

NYSE:HUM

Release Versions

Contacts

Kelley Murphy
Humana Corporate Communications
kmurphy26@humana.com
502.224.1755

More News From Humana Inc.

Humana Inc. to Present at 2025 Wolfe Research Healthcare Conference

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana’s Investor Relations page at https://humana.gcs-web.com/. The company suggests webcast participants sign on approximately 15 minutes in advance of the presentation to...

Humana Reports Third Quarter 2025 Financial Results; Affirms Full Year 2025 Adjusted EPS Guidance

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below. Consolidated income before income taxes and equity in net losses (pretax results) in millions 3Q25 (a) 3Q24 (a) Y...

Humana Board Declares Payment of Quarterly Dividend to Stockholders

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 30, 2026 to stockholders of record as of the close of business on December 26, 2025. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the million...
Back to Newsroom